Immuneering (IMRX) Current Leases (2020 - 2026)
Immuneering (IMRX) recorded quarterly Current Leases of $412835.0 in Q1 2026, up 3.96% quarter-over-quarter from $397104.0 in Q4 2025, and up 17.11% on a YoY basis from $352521.0 in Q1 2025.
Immuneering (IMRX) Current Leases (2020 - 2026) Analysis & Trends
Immuneering's Current Leases history runs 7 years deep, the most recent figure standing at $412835.0 for Q1 2026.
- In Q1 2026, Current Leases rose 17.11% year-over-year to $412835.0; the TTM figure through Mar 2026 stood at $412835.0 (up 17.11% YoY), while the FY2025 annual figure was $397104.0, up 17.33% from the prior year.
- Current Leases was $412835.0 for Q1 2026 at Immuneering, up from $397104.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $412835.0 in Q1 2026 to a low of $265419.0 in Q1 2022.
- Historically, Current Leases has averaged $336540.2 across 5 years, with a median of $332675.0 in 2023.
- The sharpest annual moves came in 2022 and 2023: Current Leases soared 272.84% in 2022, then declined 20.76% in 2023.
- A 5-year view of Current Leases shows it stood at $378723.0 in 2022, then slipped by 20.76% to $300107.0 in 2023, then advanced by 12.77% to $338438.0 in 2024, then advanced by 17.33% to $397104.0 in 2025, then climbed by 3.96% to $412835.0 in 2026.
- The last three Current Leases figures came in at $412835.0 (Q1 2026), $397104.0 (Q4 2025), and $381760.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Immuneering | 255.40 Mn | 255.40 Mn | - | 412,835.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 412,835.00 |
| Dec 31, 2025 | 397,104.00 |
| Sep 30, 2025 | 381,760.00 |
| Jun 30, 2025 | 366,959.00 |
| Mar 31, 2025 | 352,521.00 |
| Dec 31, 2024 | 338,438.00 |
| Sep 30, 2024 | 324,702.00 |
| Jun 30, 2024 | 311,459.00 |
| Mar 31, 2024 | 298,543.00 |
| Dec 31, 2023 | 300,107.00 |
| Sep 30, 2023 | 301,633.00 |
| Jun 30, 2023 | 332,675.00 |
| Mar 31, 2023 | 363,238.00 |
| Dec 31, 2022 | 378,723.00 |
| Sep 30, 2022 | 308,694.00 |
| Jun 30, 2022 | 286,374.00 |
| Mar 31, 2022 | 265,419.00 |
| Dec 31, 2021 | 274,039.00 |
| Sep 30, 2021 | 82,795.00 |
| Jun 30, 2021 | 80,605.00 |